Financials data is unavailable for this security.
View more
Year on year Bayer AG 's revenues fell -6.11% from 50.74bn to 47.64bn. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from a gain of 4.15bn to a loss of 2.94bn.
| Gross margin | 57.14% |
|---|---|
| Net profit margin | -1.87% |
| Operating margin | 4.24% |
| Return on assets | -0.78% |
|---|---|
| Return on equity | -2.75% |
| Return on investment | -1.06% |
More ▼
Cash flow in EURView more
In 2023, Bayer AG increased its cash reserves by 14.23%, or 736.00m. The company earned 5.12bn from its operations for a Cash Flow Margin of 10.74%. In addition the company used 3.52bn on investing activities and also paid 679.00m in financing cash flows.
| Cash flow per share | 7.39 |
|---|---|
| Price/Cash flow per share | 2.65 |
| Book value per share | 31.11 |
|---|---|
| Tangible book value per share | -20.04 |
More ▼
Balance sheet in EURView more
| Current ratio | 1.32 |
|---|---|
| Quick ratio | 0.8059 |
| Total debt/total equity | 1.35 |
|---|---|
| Total debt/total capital | 0.5728 |
More ▼
Growth rates in EUR
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -95.42% and -170.87%, respectively. Additionally, five year annualized dividend per share growth is in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 3.73% |
|---|---|
| Div growth rate (5 year) | -47.66% |
| Payout ratio (TTM) | -- |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 76.00 |
More ▼
